Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 4/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17378268 | 0.90 | ACE (0.47) | ACERENRAB9A | |
| SCHEMBL26724818 | 0.90 | ACE (0.47) | ACERENRAB9A | |
| SCHEMBL871820 | 0.77 | ACE (0.61) | ACERENRAB9A | |
| SCHEMBL19111008 | 0.76 | DPP4 (0.48) | ACERENDPP4 | |
| SCHEMBL26223783 | 0.76 | DPP4 (0.48) | ACERENDPP4 | |
| SCHEMBL15791258 | 0.72 | SMN1; SMN2 (0.49) | SMN1; SMN2ACERENRAB9A | |
| SCHEMBL26724942 | 0.72 | SMN1; SMN2 (0.49) | SMN1; SMN2ACERENRAB9A | |
| SCHEMBL12197909 | 0.71 | HPGD (0.48) | SMN1; SMN2 | |
| SCHEMBL12457127 | 0.71 | HPGD (0.48) | SMN1; SMN2 | |
| SCHEMBL26724930 | 0.71 | SMN1; SMN2 (0.47) | SMN1; SMN2ACERENRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2813512-B1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2021-03-31 | — | — | EP | disclosed |